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ABSTRACT: A series of novel 8-aminophenoxazin-3-one and 7-aminophenoxazin-3-one chromogens and their corresponding
β-alanine derivatives were synthesized and evaluated for their ability to detect β-alanyl aminopeptidase activity in bacteria known
to hydrolyze β-alanine derivatized substrates. The results provided insight into the structural requirements for eﬀective
visualization of enzymatic activity and the mechanism of formation of phenoxazinon-3-ones. 8-Aminophenoxazin-3-one
substrates 23c, 23d, and 23e were prepared in good to high overall yield and were selective for β-alanyl aminopeptidase activity
in bacteria, producing a lighter agar background coloration facilitating visualization of colored colonies, with variable localization
to the colonies, but had lower sensitivities for the detection of Pseudomonas aeruginosa in comparison to the analogous 7-
aminophenoxazin-3-one substrates. The synthetic methodology employed here allows the preparation of a range of substrates for
evaluation and the establishment of structure−activity relationships. For example, the 2-pentyl substituted aminophenoxazin-3-
one 22b performed with analogous sensitivity to the corresponding 1-pentyl-7-aminophenoxazin-3-one substrate 1 used
commercially, highlighting that the position of the pentyl substituent can be varied while maintaining detection sensitivity.
1. INTRODUCTION
β-Alanine derivatives of 7-aminophenoxazin-3-one are eﬃcient
markers of β-alanine aminopeptidase activity,1 an enzyme
recently identiﬁed in Pseudomonas sp.2 but also suspected to be
produced by Serratia marcescens and Burkholderia cepacia.
Culture of these bacteria on medium containing analogues of 7-
N-(β-alanyl)aminophenoxazin-3-one,1 analogues of 9-(4-N-[β-
alanyl]aminophenyl)acridines,3 and analogues of 9-(4-N-[β-
alanyl]aminophenyl)-10-methylacridinium salts4 produce
brightly colored colonies, resulting from the enzymatic
hydrolysis of these chromogenic substrates.
The Gram negative rod-shaped bacterium Pseudomonas
aeruginosa is an opportunistic pathogen that is responsible for
about 10% of hospital acquired infections in the U.S. and UK.
As a result of its nutritional versatility, P. aeruginosa is a severe
threat to immunocompromised patients, particularly neonatal
and elderly patients; it is the most serious pathogenic cause of
ventilator-associated pneumonia (VAP), colonizes the respira-
tory system of up to 80% of patients with cystic ﬁbrosis, and is
widely found in patients with AIDS and chemotherapy-induced
neutropenia and organ transplant recipients. It is one of the
“ESKAPE” pathogens identiﬁed as a signiﬁcant clinical threat
due to its ability to cause severe disease in humans.5
Once established, infections due to P. aeruginosa are diﬃcult
to treat eﬀectively due to the intrinsic resistance aﬀorded by the
combination of thick mucus secretion, broad spectrum eﬄux
pumps and, increasingly, acquired resistance to many
antibacterial agents. Delays in the appropriately directed
therapy allow this bacterium to colonize a wound or the
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respiratory system and to become established, resulting in poor
clinical outcomes and increased patient morbidity and mortal-
ity. The production of necrosis-causing toxins, e.g., type II
secreted eﬀectors, such as ExoU and ExoT, in approximately
65% of hospital-acquired P. aeruginosa strains places an
additional urgency on the rapid detection and appropriate
treatment of this opportunistic pathogen.6
The substrate 7-N-(β-alanyl)amino-1-pentylphenoxazin-3-
one TFA salt 1 (Figure 1) possesses excellent properties for
accelerating the detection of P. aeruginosa in clinical samples:
relatively low toxicity to P. aeruginosa, high sensitivity to most
P. aeruginosa strains, and a high aﬃnity of the released
chromogen for the bacterial colonies, leading to minimal
diﬀusion of the intense color in agar medium.1 This substrate
has been included in a chromogenic medium developed
speciﬁcally for the detection of P. aeruginosa (chromID P.
aeruginosa, bioMeŕieux)7 and addresses the need to identify
quickly and accurately P. aeruginosa in clinical samples. The
only slight limitations associated with the use of this substrate
are the background color it imparts to the agar and the nonideal
synthetic route to the chromogen, which leads to mixtures of
precursors that necessitate separation of mixed products at a
Figure 1. 7-N-(β-Alanyl)amino-1-pentylphenoxazin-3-one TFA salt 1 and 8-aminophenoxazin-3-one 2a.
Scheme 1. Synthetic Strategy for 8-Aminophenoxazin-3-ones 2a−fa
aReagents and conditions: (a) mCPBA, DCM, RT; (b) 10% aq NaOH, MeOH, RT; (c) 4a,c−f, DMSO, Et3N, RT, 4b, DMSO, DBU, RT; (d)
DCM, BBr3 (1M in DCM), −78°C to RT; (e) MeOH, H2O, 0 °C; (f) H2, MeOH, Pd/C 5%; (g) MeOH, Et3N, MnO2 or Ag2O; (h) cerium(IV)
ammonium nitrate, CH3CN, H2O, RT; (i) H2, Pd/C 5%, EtOAc/MeOH; (j) MeOH, Ag2O or MnO2.
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late stage by extensive chromatography.1 Chromogens with
comparable performance that are more readily synthesized in
high purity are of interest for their potential to oﬀer new
economically attractive chromogenic media for P. aeruginosa.
We have previously reported the synthesis of some alkyl
substituted 7-aminophenoxazin-3-ones via the preparation of
2,5-dinitro-2,5-dimethoxydiphenylether intermediates, which,
when subjected to demethylation followed by catalytic
hydrogenation, spontaneously cyclized to the corresponding
7-aminophenoxazin-3-ones upon exposure to air.1 Following
the successful microbiological testing of the 7-aminophenox-
azinones, we have prepared 8-aminophenoxazin-3-one 2a
(Figure 1) using analogous synthetic methodology. This
substrate displayed visually interesting chromogenic properties,
suggesting its substituted analogues, and their β-alanyl
derivatives, would be worthy of further study. We present
here the results of studies that highlight the utility of this
synthetic procedure, particularly the scope for synthesis of
variously substituted analogues, the good overall yields, and the
ready isolation of pure and easily characterizable intermediates
at each stage, culminating in the synthesis and evaluation of a
series of substituted 8-N-(β-alanyl)aminophenoxazin-3-one
derivatives of 2a as potential chromogenic agents for the
detection of P. aeruginosa in clinical samples, along with two
novel substituted 7-N-(β-alanyl)-aminophenoxazin-3-one de-
rivatives for direct comparison.
2. RESULTS AND DISCUSSION
2.1. Chemistry. The synthesis of the 8-aminophenoxazi-
nones utilized the previous successful synthetic approach to 11
and 2a, proceeding through diphenylethers 6, which were
demethylated, then reduced and oxidatively cyclized to the
desired 8-aminophenoxazinones 2 (Scheme 1).
The 2,4-dinitro-2,5-dimethoxydiphenylethers 6a−f were
prepared by nucleophilic aromatic substitution of 2,4-dinitro-
1-ﬂuorobenzene 5 (Sanger’s reagent, DNFB)8 by the phenols
Scheme 2. Reduction and Oxidative Cyclization of Dinitrodihydroxydiphenyl Ethers 7a,b and Dinitrobenzoquinones 8a−e
Proceeded through the Diamino Intermediates 9a,b and 11a−e, Respectively, to Yield 8-Aminophenoxazinones 2a−fa
aReagents and conditions: (a) H2, Pd/C 5%, MeOH; (b) Ac2O, N2, RT; (c) aerobic oxidation; (d) Et3N, MeOH, AgO, Ag2O, or MnO2; (e) H2, Pd/
C 5%, EtOAc/MeOH; (f) MeOH, Ag2O, or MnO2.
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4a−f, according to the conditions previously described
(Scheme 1). It was anticipated that lipophilic substituents
would improve the localization of chromogenic substrates to
the bacterial colonies grown on agar medium and so help to
avoid the diﬀusion of color after substrate hydrolysis.
Accordingly, substituted 2,5-dimethoxyphenols 4a−d were
prepared from the correspondingly substituted 2,5-dimethox-
ybenzaldehydes 3a−d, via the Baeyer−Villiger oxidation.9
Dimethoxyphenols 4e−f were prepared synthetically by the
introduction of alkyl or aryl substituents and an aldehyde
group, followed by Baeyer−Villiger oxidation, as described in
the Supporting Information.
Initially, the dealkylation of diphenylethers 6a,b,d was
attempted using boron tribromide (BBr3).
1 The reaction was
successful for diphenylethers 6a,b; in the case of 6b, 2,4-
dinitrophenoxy-3,4,6-trimethyl-2,5-benzoquinone 8a was
isolated in addition to the expected product 7b. The use of
BBr3 was problematic in the case of the tert-butyl derivative 6d,
where none of the expected product could be isolated, possibly
due to displacement of the tert-butyl group, resulting in
multiple side reactions, but suﬃcient quantities of the
byproducts could not be isolated for the purposes of
characterization. However, oxidative dealkylation of the
diphenylethers 6c−f using cerium(IV) ammonium nitrate
(CAN)10 produced the 2,4-dinitrophenoxybenzoquinones
8b−e in good to high yield (Scheme 1).
Following our previous synthetic route,1 2,4-dinitro-2,5-
dihydroxydiphenylethers 7a−b were hydrogenated in a Berghof
apparatus with palladium on charcoal (Pd/C, 5%) as catalyst
(Scheme 2). The ﬁrst attempts at aerobic oxidation of the
resulting 2,4-diamino-2,5-dihydroxydiphenylether intermedi-
ates 9a,b did not yield the expected 8-aminophenoxazinones
2a,b but led instead to unidentiﬁed products. The isolation of
2,4-diacetamido-2,5-dihydroxydiphenylether 10a, resulting
from the addition of acetic anhydride immediately after the
hydrogenation of 7a, conﬁrmed the intermediate formation of
2,4-diamino-2,5-dihydroxydiphenylether 9a. Previous work on
the mechanism of oxidation of duroquinone11 suggested that
the formation of 8-aminophenoxazin-3-one would be facilitated
by higher pH due to a more facile oxidation of the phenolate;
however, this was not suﬃcient to drive the oxidative
cyclization and 8-aminophenoxazinones 2a,b were isolated in
high yield only after addition of a metal oxide (AgO, Ag2O, or
MnO2, Scheme 2).
2,4-Dinitrophenoxybenzoquinones 8a−e were subjected to
the same catalytic hydrogenation procedure (Scheme 2),
resulting in rapid formation of the 8-aminophenoxazinones
2b−f. The isolation of diacetamidophenoxybenzoquinones
12a−c, resulting from the addition of acetic anhydride
immediately after reduction of 8b−d, established the existence
of 2,4-diaminophenoxy-2,5-benzoquinones 11a−e as inter-
mediates in the formation of 8-aminophenoxazinones 2b−f
(Scheme 2).
The formation of 8-aminophenoxazinones 2 from both the
dihydroxydiphenylethers 9 and phenoxybenzoquinones 11
provides evidence for the previously proposed pathway1
(Scheme 2).
Novel 7-aminophenoxazinones 17a,b were also prepared via
the catalytic hydrogenation of 2,5-dinitrophenoxy-2,5-benzo-
quinones 15a,b (Scheme 3). The precursor dimethoxydiphe-
nylethers 14a,b were obtained via coupling of 2,5-dinitro-1-
ﬂuorobenzene 13 and phenols 4d,e using sodium hydride in
DMF.1 The yields of diphenylethers 14a,b were moderate,
presumably due to the lower electrophilic character of C-1 in
13, compared to C-1 in Sanger’s reagent 5. CAN oxidation to
the corresponding dinitrophenoxybenzoquinones 15a,b and
catalytic reduction, followed by aerial oxidation, gave the
expected 7-aminophenoxazinones 17a,b in excellent yield. As
Scheme 3. Preparation of 7-Aminophenoxazinones 17a,ba
aReagents and conditions: (a) NaH, dry DMF, RT; (b) CAN, CH3CN, H2O; (c) H2, Pd/C 5%, MeOH/EtOAc; (d) Ac2O, N2, RT; (e) MeOH,
Ag2O, or MnO2.
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with the formation of 2a,b, the addition of a metal oxide (AgO
or MnO2) during the aeration greatly accelerated the formation
of 17a,b. Addition of acetic anhydride under a protective
atmosphere immediately after the hydrogenation of 15a
p r o d u c e d 2 , 5 - d i a c e t a m i d o - 2  , 5  - d i h y d r o x y -
4-tbutyldiphenylether 18a in excellent yield, providing
evidence for 2,5-diamino-2,5-dihydroxy-4-tbutyldiphenylether
16a as the direct product of hydrogenation (Scheme 3).
A facile redox couple of 2,5-diamino-2,5-dihydroxydiphe-
nylether 16 and 2,5-diaminophenoxybenzoquinone (not shown
in Scheme 3) accounts for the ease of formation of 7-
aminophenoxazinone 17a,b. This is not reﬂected by the redox
couple of 2,4-diamino-2,5-dihydroxydiphenylether 9 and 2,4-
diaminophenoxybenzoquinone 11, which requires harsher
conditions: 2,4-diamino-2,5-dihydroxydiphenylethers 9a,b
did not oxidize upon aerobic oxidation and 2,4-diaminophe-
noxybenzoquinones 11a−e were not reduced to the corre-
sponding dihydroxydiphenylethers under the hydrogenation
conditions used (Scheme 2). It appears that the position of the
amino group, whether it is meta or para to the oxygen bridging
atom (with the second amino group always being ortho to the
oxygen bridging atom), is a key determinant in the oxidation of
diamino-2,5-dihydroxydiphenylethers and the reduction of
diaminophenoxybenzoquinone species (Schemes 2 and 3).
However, it remains unclear how the positioning of the amino
group could aﬀect, in this particular case, the radical process
involved in oxidation and reduction.
Coupling of 7- and 8-aminophenoxazinones to β-alanine was
achieved using the mixed anhydride method. While 7-
aminophenoxazinones 17a,b required reduction to 7-amino-3-
hydroxyphenoxazines 19a,b prior to amide bond formation,1 8-
aminophenoxazinones 2a−f reacted readily with the activated
anhydride. TFA removal of the tBoc protecting group from
both the 7-aminophenoxazinone 20a,b and 8-aminophenox-
azinone intermediates 21a−f provided the desired chromogenic
substrates 22a,b and 23a−f (Scheme 4).
2.2. Chromogenic Properties. Quantitative information,
relating the chromogenic properties of analogous phenoxazi-
nones 2d,e and 17a,b to the positioning of the auxochromic
amino group, was obtained from their UV−visible absorbance
spectra (50 μM in MeOH, Table 1). The 8-aminophenoxazin-
3-ones 2d,e yielded violet-colored methanolic solutions (λmax =
528−533 nm), whereas the 7-aminophenoxazin-3-ones 17a,b
produced bright red−pink colored methanolic solutions (λmax =
536−540 nm, Table 1). The auxochrome position only slightly
aﬀected the λmax values for phenoxazinones 2d,e and 17a,b but
Scheme 4. Amide Bond Formation and tBoc Deprotection to Form 7-N-(β-Alanyl)-aminophenoxazin-3-ones 22a,b and 8-N-(β-
Alanyl)-aminophenoxazin-3-ones 23a−fa
aReagents and conditions: (a) H2, Pd/C 5%, DMF; (b)
tBoc-β-alanine, IBCF, dry THF, N-methylpiperidine, 0°C, 48 h; (c) TFA, RT, 15 min.
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had a remarkable eﬀect on the molar absorptivity (ε) values,
which were, on average, almost 6-fold higher for 7-amino-
phenoxazinones 17a,b compared to their corresponding 8-
aminophenoxazinones 2d,e, presumably due to the extended
electron conjugation in chromogens 17a,b, which is not
possible in 2d,e (Scheme 5).
β-Alanine derivatization of the auxochrome resulted in a
hypsochromic shift in the spectra of both the 7-amino- 22a,b
(71−75 nm) and 8-aminophenoxazinones 23d,e (64−65 nm)
(Table 1). The amide derivatization most dramatically aﬀected
the ε values for 7-aminophenoxazinones 17a,b, decreased by
nearly a factor of 2, inhibiting the extended electron
conjugation within the phenoxazinone ring system (Scheme
5). Conversely, the ε values of 8-aminophenoxazinones 2d,e
were slightly increased after derivatization with β-alanine
(Table 1).
2.3. Microbiological Evaluation. Spot test microbiolog-
ical screening, against a range of clinically relevant micro-
organisms, was used to compare the six β-alanyl substrates
based on the 8-aminophenoxazinone core, 23a−f, and the two
β-alanyl substrates based on the 7-aminophenoxazinone core,
22a,b, to the reference substrate, 7-N-(β-alanyl)amino-1-
pentylphenoxazin-3-one 1 (Table 2). Enzymatic activity was
anticipated for strains of P. aeruginosa and Serratia marcescens,
which were previously shown to hydrolyze β-alanyl-derivatized
chromogenic substrates; detection of Burkholderia cepacia was a
possible, but less certain, outcome due to variable expression of
β-alanyl aminopeptidase in this species.1
8-Aminophenoxazinone substrates 23a (1,2,4-unsubstituted)
and 23f (1-phenyl) lacked toxicity toward the range of Gram
positive and Gram negative bacteria and yeasts evaluated but
failed to evidence any β-alanine aminopeptidase activity after 24
h and 48 h of incubation. Toxicity toward Gram positive
bacteria and yeasts was previously observed with a range of 7-
N-(β-alanyl)aminophenoxazinones1 and was observed for the
other substrates tested here; the absence of any toxic eﬀect is a
desirable property for a molecule used in the detection and
identiﬁcation of bacteria. The lack of substrate hydrolysis from
23a and 23f may reﬂect poor uptake of these substrates.
Substrate 23b (1,2,4-trimethyl) also had a poor response
toward β-alanine aminopeptidase: after 24 h, a weak response
could be seen for two P. aeruginosa strains only; after 48 h,
hydrolysis could be seen for all the strains of P. aeruginosa and
S. marcescens but none of the B. cepacia (sensitivity of detection:
77.8% after 48 h, Table 2). Although this substrate was
generally nontoxic toward the microorganisms tested and the
color it released was a distinguishing pink to pale purple, it
diﬀused into the medium, making individual bacterial colony
visualization diﬃcult in this plate-based culture system.
Substrate 23c (1,2-dimethyl) showed similar results to 23b in
terms of the sensitivity of detection (77.8% after 48 h) but had
an enhanced visual response after only 24 h of incubation, with
less diﬀusion into the medium. Substrates 22a (7-N,2-tbutyl),
23d (8-N,2-tbutyl), 22b (7-N,2-npentyl), and 23e (8-
N,2-npentyl) showed the best responses toward β-alanine
aminopeptidase, with results similar to 1 and a positive reaction
for all of the tested strains of P. aeruginosa and S. marcescens
(Table 2). Except for 22b, these substrates were also the most
toxic, inhibiting the growth of most (22a, 23d, and 1) or all
(23e) of the Gram positive strains (Table 2). Substrates 22b
and 23e showed better localization of the released chromogen
to the bacterial colonies compared to substrates 22a and 23b−
d, with virtually no diﬀusion of the color, facilitating detection
and identiﬁcation of individual bacterial colonies. The
prevailing trend in Table 2, when considering substrate
hydrolysis and substrate toxicity, reveals that these eﬀects
correlate to the overall substrate lipophilicity according to the
calculated log P (ChemDraw). A concomitant increase in
hydrolysis in Gram negative bacteria and toxicity to Gram
positive bacteria, also tend to suggest better uptake into
microorganisms for lipophilic substrates, indicated by a higher
cLogP, than those with lower lipophilicity.
Streaked plates (Figure 2) allowed further comparison of
substrates 22b (7-N,2-npentyl) and 23e (8-N,2-npentyl) against
the standard 1 (7-N,1-npentyl), after 24 h incubation, as an
agent for the detection of S. marcescens: the presence of a
lipophilic 2-npentyl chain in each of these substrates allows for
good localization of the released chromogen to the bacterial
colonies. Both 7-(β-alanyl)pentylaminophenoxazinones 22b
and 1 imparted a strong background color to the agar plates,
which is a disadvantage as it impairs the visualization of the
bacterial colonies. Although the released chromogen was not as
intensely colored as that from the standard, 7-N-(β-alanyl)-
amino-1-pentylphenoxazinone 1, bacterial enzymatic hydrolysis
of novel 8N-(β-alanyl)amino-2-pentylphenoxazinone substrate
23e produced a distinctive purple color and elicited good
contrast between background and bacterial colonies, oﬀering
some improvement in their visualization (Figure 2).
Finally, substrates 22b and 23e were tested against a wider
range of 30 P. aeruginosa strains to evaluate their sensitivity
(Table 3). Use of the medium containing substrate 22b allowed
the detection of 100% of these strains and matched the results
obtained with the standard 1, while the 8-aminophenoxazinone-
based substrate 23e detected 80% of the β-alanine amino-
peptidase producing strains (Table 3).
Table 1. Impact of Peptide Derivatization on λmax and ε
Values for Phenoxazinones 2d,e and 23a,b (50 μM in
MeOH)a
compd λmax (nm) Δλ (nm) A ε (dm
3·mol−1·cm−1)
2d (chromogen) 536 0.295 5900
23d (substrate) 472 64 0.348 6960
2e (chromogen) 540 0.322 6400
23e (substrate) 475 65 0.388 7760
17a (chromogen) 533 1.804 36080
22a (substrate) 458 75 0.922 18440
17b (chromogen) 528 1.554 31080
22b (substrate) 457 71 0.861 17220
a8-Aminophenoxazinones a−c and f were not included in the
comparison as their corresponding 7-aminophenoxazinone analogues
were not synthesized.
Scheme 5. Extended Electron Conjugation in 7-
Aminophenoxazin-3-one Derivatives
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3. CONCLUSIONS
The 8-N-(β-alanyl)aminophenoxazin-3-ones 23b−e displayed
selective β-alanyl aminopeptidase sensitivity, producing colored
bacterial colonies with P. aeruginosa and S. marcescens as
expected, which was enhanced after 48 h of incubation. In
particular, the 2-tbutyl- 23d and 2-npentyl- 23e 8-N-(β-
alanyl)aminophenoxazin-3-ones compared well to the standard
1 after 48 h, with the advantage of lower background color,
which resulted in enhanced visualization of bacterial colonies.
The lack of diﬀusion of 23e into the medium and its distinctive
color were additional advantages, tempered by the lower
sensitivity of this substrate to a wider range of P. aeruginosa
strains. However, alternative amino acids, such as L-alanyl or L-
pyroglutamyl, are used to target a range of other substrates to
Table 2. Spot Test Screening of Substrates 23a−f, 22a,b, and 1a against a Range of Clinically Relevant Gram Positive and Gram
Negative Bacteria and Two Strains of Yeast (cLogP, ChemDraw)
visualization of coloration after 24 h and (48 h)b
bacterial strain reference no.
23a,
cLogP
0.37
23b,
cLogP
0.32
23c, cLogP
0.34
23d, cLogP
1.81
23e, cLogP
2.18
23f,
cLogP
1.64
22a, cLogP
1.81
22b, cLogP
2.18
1, cLogP
2.18
Gram Negative Bacteria
E. coli ATCC 8739 − (−)c − (−) − (−) − (−) − (−) − (−) − (−) − (−) − (−)
E. coli ATCC 25922 − (−) − (−) − (−) − (−) − (−) − (−) − (−) − (−) − (−)
E. cloacae ATCC 13047 − (−) − (−) − (−) − (−) − (−) − (−) − (−) − (−) − (−)
S. typhimurium NCT C74 − (−) − (−) − (−) − (−) − (−) − (−) − (−) − (−) − (−)
M. morganii CIP 103690 − (−) − (−) − (−) − (−) − (−) − (−) − (−) − (−) − (−)
C. freundii CIP 103547 − (−) − (−) − (−) − (−) − (−) − (−) − (−) − (−) − (−)
Y. enterocolitica NSB 29163 − (−) − (−) − (−) − (−) − (−) − (−) − (−) − (−) − (−)
P. rettgeri ATCC 9250 − (−) − (−) − (−) − (−) − (−) − (−) − (−) − (−) − (−)
P. aeruginosa NCTC 10662 − (−) − (++) + (++) + (++) − (++) − (−) ++ (++) − (+) + (++)
P. aeruginosa NA − (−) ± (+) + (+) + (+) + (+) − (−) ++ (++) ++ (++) ++ (++)
P. aeruginosa NA − (−) ± (+) + (+) + (+) + (++) − (−) ++ (++) ++ (++) ++ (++)
S. marcescens NA − (−) − (+) + (++) + (++) ++ (++) − (−) ++ (++) + (++) + (++)
S. marcescens NCTC 10211 − (−) − (+) ± (++) − (++) + (++) − (−) ++ (++) + (+) ++ (++)
S. marcescens ATCC 264 − (−) − (+) − (+) − (+) − (++) − (−) ± (+) + (+) + (++)
S. marcescens ATCC 43861 − (−) − (+) − (++) ++ (++) + (++) − (−) ++ (++) + (++) + (++)
B. cepacia ATCC BA-246 − (−) − (−) − (−) − (−) − (−) − (−) − (−) − (−) − (−)
B. cepacia LMG 1222 − (−) − (−) − (−) − (+e) − (+e) − (−) − (−) − (−) − (++e)
B. cepacia ATCC BAA-1911 − (−) − (−) − (−) − (+e) − (++e) − (−) − (±) − (+) + (++e)
Gram Positive Bacteria
B. subtilis ATCC 6633 − (−) − (−) + (++) NG (NG) NG (NG) − (−) − (−) − (−) − (−)
MRSA ATCC 4330 − (−) − (−) − (−) NG (NG) NG (NG) − (−) NG (NG) − (−) NG (−)
S. aureus NCTC 6571 − (−) − (−) NG (NG)d NG (NG) NG (NG) − (−) NG (NG) NG(NG) NG(NG)
E. faecium NCTC 7171 − (−) − (−) − (−) − (−) NG (NG) − (−) − (−) − (−) NG (NG)
E. faecalis NCTC 775 − (−) − (−) − (−) NG (−) NG (NG) − (−) − (−) − (−) NG (NG)
S. pyogenes NCTC 8306 − (−) − (−) NG (NG) NG (NG) NG (NG) − (−) NG (−) − (−) NG (NG)
L.
monocytogenes
ATCC BAA-751 − (−) − (−) − (−) NG (NG) NG (NG) − (−) NG (−) − (−) NG (NG)
S. epidermidis NCTC 11047 − (−) − (−) − (−) NG (NG) NG (NG) − (−) NG (NG) NG (NG) NG (NG)
Yeasts
C. albicans ATCC 90028 − (−) − (−) − (−) − (−) NG (−) − (−) − (−) − (−) NG (−)
C. glabrata ATCC 64677 − (−) − (−) − (−) − (−) NG (−) − (−) − (−) NG (NG) − (−)
aEach substrate was tested at a concentration of 40 mg/L. bResults after 24 h and 48 h of incubation at 37 °C. c”−“ means no coloration, “ ± ”
means coloration with weak intensity, “+” means coloration with medium intensity, “++” means coloration with strong intensity. dNG, no growth.
eThis strain produces a yellow pigment.
Figure 2. Comparative microbiological results for 7-N-(β-alanyl)amino-2-pentylphenoxazin-3-one 22b, 8-N-(β-alanyl)amino-2-pentylphenoxazin-3-
one 23e, and 7-N-(β-alanyl)amino-1-pentylphenoxazin-3-one 1 (40 mg/L, 24 h incubation).
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speciﬁc bacteria, which have diﬀerent sensitivities to that of P.
aeruginosa to novel substrates, hence the desirable color, lack of
diﬀusion, and low background color oﬀered by 2-npentyl-8-N-
aminophenoxazin-3-one, make amino acid derivatives of this
molecule especially interesting for new bacterial detection
applications.
The two 7-N-(β-alanyl)aminophenoxazin-3-ones 22a and
22b displayed similar activity to standard 1 as β-alanyl
aminopeptidase substrates, with excellent sensitivity of 22b to
the wider range of P. aeruginosa strains tested, although the
resulting color of the bacterial colonies was slightly less intense
and, like standard 1, there was considerable background color
in the agar plates.
This study highlights the scope of this synthetic route to
phenoxazinones, allowing the preparation of a range of
chromogenic substrates in good overall yields such as the
new 8-aminophenoxazin-3-one series reported here, facilitating
structure−activity relationships and the optimization of the
substrate properties. At each stage, the intermediates can be
isolated and characterized, in contrast to the previous synthetic
route to the 1-pentyl analogue 1, while improvements to
substrate performance may be achieved by tuning the
substitution pattern of the quinonoid portion of the
phenoxazinone ring. Increased hydrophobic properties
achieved via alkyl substituents at the 1- and/or 2-positions
enhance the color, prevent the spread of the chromogen into
the medium, and also appear to increase the amount of
substrate hydrolyzed by facilitating substrate uptake into the
bacteria. Longer alkyl chains (C5/npentyl) improved the
substrate properties; introduction of an aromatic substituent,
on the other hand, completely eliminated the detection of
enzymatic activity. 7-N-(β-Alanyl)amino-1-pentylphenoxazin-3-
one 1 has proved an excellent substrate for the detection of P.
aeruginosa in culture media due to the localization within
bacterial colonies as a result of the incorporation of the
hydrophobic pentyl chain; this work demonstrates the
accessibility of a range of alkyl substituted analogues, thus
enabling other applications such as in liquid media where
localization within colonies is not desired. The synthetic route
described here may also allow the development of a substrate
which imparts lower background color to the medium.
This work has further established the utility of chromogenic
substrates based on 7-aminophenoxazin-3-ones for the
detection of β-alanyl aminopeptidase producers (e.g., P.
aeruginosa and Serratia marcescens). The 8-aminophenoxazin-
3-one analogues 23c−e display distinct advantages: their
coupling to β-alanine does not require prior reduction as
they couple directly with an activated anhydride and they result
in decreased background color of the agar plate (facilitating
visualization of the bacterial colonies). The two novel 7-
aminophenoxazin-3-ones 22a and 22b have comparable
properties to the standard 1 and could make suitable substitutes
for the detection and identiﬁcation of P. aeruginosa in clinical
samples using culture methods.
4. EXPERIMENTAL SECTION
4.1. Chemistry. The synthesis of two example chromogenic
substrates 22b and 23e are provided below. The purity of all
intermediates, except 2b,c, was determined by elemental analysis and
was within 0.4% of the calculated values. The purity of compounds
2b,c and ﬁnal substrates 22a,b and 23a−f was ≥95%, as determined by
LC-MS. All other syntheses are detailed in the Supporting
Information.
4.1.1. General. All commercially available reagents and solvents
were obtained from Sigma-Aldrich, Fluka, or Riedel-de-Haan and were
used without further puriﬁcation. Melting points were recorded on a
Reichart-Koﬂer hot-stage microscope apparatus and are uncorrected.
Infrared spectra were recorded in the range 4000−600 cm−1 using a
PerkinElmer Spectrum BX FT-IR spectrophotometer. NMR spectra
were obtained using a Bruker Ultrashield 300 spectrometer at 300
MHz for 1H spectra or at 75 MHz for 13C spectra. Low-resolution
mass spectra were recorded on a Bruker Esquire 3000plus analyzer
using an electrospray source in either positive or negative ion mode.
High resolution accurate mass measurements were collected by the
EPSRC National Mass Spectrometry Facility at Swansea University.
Elemental analyses were performed using an Exeter Analytical CE-440
elemental analyzer. Thin layer chromatography was performed on
Merck silica gel 60F254. Fisons silica gel 60 (35−70 μm) was used for
ﬂash chromatography; the samples were preabsorbed onto silica gel 60
(35−70 μm). LC-MS was performed using an Agilent 1200 Inﬁnity
series HPLC system and an Agilent 6120 quadruple LC-MS detector
(API-ES). Mobile phase A, H2O/MeOH (90:10, with 0.1% TFA);
mobile phase B, H2O/MeOH (10:90, with 0.1% TFA), A:B (45:65),
ﬂow rate 1 mL/min, Column: ACE 5 C18 (250 mm × 4.6 mm, 5 μm),
column temperature was not controlled, injection volume 20 μL. The
data were analyzed using Agilent ChemStation.
4.1.2. 2,5-Dimethoxy-4-pentylphenol 4e. 2,5-Dimethoxy-4-pentyl-
benzaldehyde 3e (3.44 g, 14.58 mmol) in DCM (70 mL) was cooled
to 0 °C, and meta-chloroperbenzoic acid (3.77 g, 24.79 mmol) was
added portionwise. The reaction mixture was maintained at 0 °C for 1
h, allowed to warm to RT, and left overnight. After reﬂux for 6 h, it was
allowed to cool to RT before being washed with a 5% aqueous solution
of NaHCO3 (3 × 100 mL) and dried (MgSO4). The solvent was
removed in vacuo. The residual oil was dissolved in methanol (20 mL)
and NaOH (10%, 50 mL) added; the resulting dark solution was
stirred for 2 h and then acidiﬁed (pH 1−2) with HCl (10%). The
resulting mixture was extracted with DCM (3 × 80 mL), and the
combined organic extracts were successively washed with NaHCO3
(5%, 100 mL), water (100 mL), and brine (100 mL) and dried
(MgSO4). The solvent was removed in vacuo and the residue
subjected to column chromatography on silica gel eluting with
petroleum ether (60−80 °C):Et2O (70:30). 2,5-Dimethoxy-4-
pentylphenol 4e was isolated as a white crystalline solid (2.66 g,
11.87 mmol, 81.4%). Recrystallization from Et2O:petroleum ether
(60−80 °C) produced white needles, mp 33−35 °C (Found: C, 69.55;
H, 9.0%. C13H20O3 requires C, 69.6; H, 9.0%.); m/z 225.0 (MH)
+;
νmax/cm
−1 3354 (O−H), 2953 and 2930 (C−H), 1598 and 1515 (C
C), 1192 and 1038 (C−O); δH (300 MHz, CDCl3) 0.96 (3H, t, J = 6.9
Hz, 5-H), 1.38−1.415 (4H, m, 3-H and 4-H), 1.58−1.63 (2H, m, 2-
H), 2.59 (2H, t, J = 7.5 Hz, 1-H), 3.81 (3H, s, 5-OCH3), 3.89 (3H, s,
2-OCH3), 5.61 (1H, s, OH), 6.60 (1H, s, 6-H), 6.73 (1H, s, 3-H); δC
(75 MHz, CDCl3) 14.1 (CH3, 5-C), 22.6 (CH2, 3-C or 4-C), 29.8
(CH2, 1-C), 30.1 (CH2, 2-C), 31.8 (CH2, 3-C or 4-C), 56.1 (CH3,
5-OCH3), 56.8 (CH3, 2-OCH3), 99.5 (CH, 6-C), 113.3 (CH, 3-C),
122.3 (quat, 4-C), 140.1 (quat, 2-C), 144.1 (quat, 1-C), 152.0 (quat, 5-
C).
4.1.3. 2,4-Dinitro-2,5-dimethoxy-4-pentyldiphenylether 6e. A
solution of 2,5-dimethoxy-4-pentylphenol 4e (2.71 g, 12.09 mmol)
and Et3N (1.69 mL, 12.09 mmol) in DMSO (50 mL) was stirred for 5
min before 2,4-dinitro-1-ﬂuorobenzene 5 (2.25 g, 12.09 mmol) was
added; the solution color turned to orange−red. After 5 h, water (200
mL) was added, resulting in the formation of a precipitate. The
mixture was extracted with DCM (3 × 100 mL), and the combined
DCM extracts were successively washed with NaOH (10%, 3 × 100
Table 3. Spot Test Evaluation of Substrates 22b and 23e (50
mg/L) as Substrates for Pseudomonas aeruginosa, Compared
to the Standard 1 (% of Strain with Positive Response after
48 h of Incubation)
species no. of strains 22b 23e 1
Pseudomonas aeruginosa 30 100% 80% 100%
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mL), water (100 mL), and brine (150 mL) and then dried (MgSO4).
The solvent was removed in vacuo and the residue recrystallized from
ethanol. 2,4-Dinitro-2,5-dimethoxy-4-pentyldiphenylether 6e was
isolated as a yellow crystalline solid (4.36 g, 11.17 mmol, 92.4%);
mp 85−87 °C (Found: C, 58.3; H, 5.7; N, 7.2%. C19H22N2O7 requires
C, 58.5; H, 5.7; N, 7.2%.); m/z 390.1 (MH)+, 413.1 (MNa)+; νmax/
cm−1 1608 (CC), 1536 and 1342 (NO2), 1212 and 1037 (C−O);
δH (300 MHz, CDCl3) 0.96 (3H, t, J = 6.9 Hz, 5-H), 1.39−1.43 (4H,
m, 3-H and 4-H), 1.62−1.67 (2H, m, 2-H), 2.66 (2H, t, J = 7.5 Hz,
1-H), 3.755 (3H, s, 2-OCH3), 3.82 (3H, s, 5-OCH3), 6.76 (1H, s,
6-H), 6.91 (1H, s, 3-H), 6.96 (1H, d, J = 9.3 Hz, 6-H), 8.31 (1H, dd,
J = 9.3, 2.7 Hz, 5-H), 8.87 (1H, d, J = 3.0 Hz, 3-H); δC (75 MHz,
CDCl3) 14.1 (CH3, 5-C), 22.6 (CH2, 3-C or 4-C), 29.6 (CH2, 2-
C), 30.1 (CH2, 1-C), 31.75 (CH2, 3-C or 4-C), 56.1 (CH3, 5-
OCH3), 56.9 (CH3, 2-OCH3), 105.6 (CH, 6-C), 115.85 (CH, 3-C),
117.4 (CH, 6-C), 122.0 (CH, 3-C), 128.65 (CH, 5-C), 131.0 (quat, 4-
C), 138.3 (quat, 2-C), 139.3 (quat, 1-C), 141.0 (quat, 4-C), 144.3
(quat, 2-C), 152.2 (quat, 5-C), 156.6 (quat, 1-C).
4.1.4. 2,5-Dinitro-2,5-dimethoxy-4-pentyldiphenylether 14b.
To a solution of 2,5-dimethoxy-4-pentylphenol 4e (2.07 g, 9.25
mmol) in dry DMF (30 mL), NaH (oil dispersion 60% w/w, 0.74 g,
18.50 mmol) was added in portions; when evolution of H2 stopped, a
solution of 2,5-dinitroﬂuorobenzene 13 (1.72 g, 9.25 mmol) in DMF
(10 mL) was added. After 5 h at RT, the deep-red solution was heated
at 50 °C for another 5 h. The reaction was allowed to cool to RT and
quenched with brine (100 mL). The resulting mixture was extracted
with DCM (3 × 80 mL) and the combined DCM layers washed with
water (100 mL) and brine (2 × 100 mL) and then dried (MgSO4).
The solvent was removed in vacuo and the residue subjected to
column chromatography, eluting with a solvent mixture of petroleum
ether (60−80 °C):Et2O (75:25). 2,5-Dinitro-2,5-dimethoxy-4-
pentyldiphenylether 14b was isolated as a bright-orange solid (1.69
g, 4.33 mmol, 46.8%). Recrystallization from EtOH produced small
yellow needles; mp 77−79 °C (Found: C, 58.3; H, 5.65; N, 7.2%.
C19H22N2O7 requires C, 58.5; H, 5.7; N, 7.2%); m/z 391.2 (MH)
+,
413.2 (MNa)+; νmax/cm
−1 2853−2952 (C−H), 1629 (CC), 1531
and 1347 (NO2), 1209 and 1038 (C−O); δH (300 MHz, CDCl3) 0.84
(3H, t, J = 6.9 Hz, 5-H), 1.25−1.30 (4H, m, 3-H and 4-H), 1.48−
1.55 (2H, m, 2-H), 2.54 (2H, t, J = 8.1 Hz, 1-H), 3.63 (3H, s, 2-
OCH3), 3.70 (3H, s, 5-OCH3), 6.63 (1H, s, 6-H), 6.785 (1H, s, 3-
H), 7.53 (1H, d, J = 2.4 Hz, 6-H), 7.83 (1H, dd, J = 9.0, 2.4 Hz, 4-H),
7.93 (1H, d, J = 8.7 Hz, 3-H); δC (75 MHz, CDCl3) 14.0 (CH3, 5-C),
22.6 (CH2, 3-C or 4-C), 29.6 (CH2, 2-C), 30.1 (CH2, 1-C), 31.8
(CH2, 3-C or 4-C), 56.1 (CH3, 5-OCH3), 56.9 (CH3, 2-OCH3),
105.6 (CH, 6-C), 112.6 (CH, 6-C), 115.9 (CH, 3-C), 116.25 (CH,
4-C), 126.1 (CH, 3-C), 130.8 (quat, 4-C), 139.5 (quat, 1-C), 142.8
(quat, 5-C), 144.4 (quat, 2-C), 150.4 (quat, 2-C), 152.2 (quat, 5-C),
152.4 (quat, 1-C).
4.1.5. General Procedure for the Preparation of 2,4-Dinitro- and
2,5-Dinitrophenoxybenzoquinones 8d and 15b. The appropriately
substituted dinitro-2,5-dimethoxydiphenylether (1 mol equivalent)
was dissolved in CH3CN (50 to 500 mL); cerium(IV) ammonium
nitrate (3 mol equiv) was dissolved in the minimum amount of water
and added slowly. The yellow solution usually darkened upon addition
of the cerium(IV) ammonium nitrate solution, followed by the
formation of a yellow precipitate soon after the addition was complete.
The resulting mixture was stirred for a further 1 h. The CH3CN was
removed under reduced pressure and, whenever possible, the
precipitate formed was collected by ﬁltration and washed with water.
It was then redissolved in DCM, the resulting solution dried (MgSO4),
and the solvent removed in vacuo. The resulting solid was
recrystallized from ethanol. When no precipitate formed and a yellow
oil/syrup was observed instead, the reaction mixture was extracted
twice with DCM and the combined organic layers washed once with
brine and dried (MgSO4). The solvent was removed under reduced
pressure and the residue either subjected to column chromatography
or recrystallized from EtOH.
4.1.5.1. 2,4-Dinitrophenoxy-4-pentyl-2,5-benzoquinone 8d.
Prepared from 2,4-dinitro-2,5-dimethoxy-4-pentyldiphenylether 6e
(2.65 g, 6.79 mmol). The crude product was puriﬁed by column
chromatography, eluting with petroleum ether (60−80 °C):EtOAc
(70:30). 2,4-Dinitrophenoxy-4-pentyl-2,5-benzoquinone 8d was
isolated as a yellow solid (2.36 g, 6.56 mmol, 96.7%). Recrystallization
from EtOH produced shiny yellow plates; mp 110−114 °C (Found:
C, 56.5; H, 4.4; N, 7.7%. C17H16N2O7 requires C, 56.7; H, 4.5; N,
7.8%.); m/z 383.1 (MNa)+; νmax/cm
−1 2927 (C−H), 1673 and 1649
(CO), 1610 (CC), 1530 and 1342 (NO2), 1224 (C−O); δH (300
MHz, CDCl3) 0.83 (3H, t, J = 6.9 Hz, 5-H), 1.26−1.29 (4H, m, 3-H
and 4-H), 1.43−1.48 (2H, m, 2-H), 2.38 (2H, td, J = 7.8, 1.2 Hz, 1-
H), 6.03 (1H, s, 6-H), 6.53 (1H, t, J = 1.5 Hz, 3-H), 7.31 (1H, d, J =
9.0 Hz, 6-H), 8.43 (1H, dd, J = 9.0, 2.7 Hz, 5-H), 8.88 (1H, d, J = 2.7
Hz, 3-H); δC (75 MHz, CDCl3) 13.9 (CH3, 5-C), 22.4 (CH2, 3-C or
4-C), 27.6 (CH2, 1-C), 28.9 (CH2, 2-C), 31.45 (CH2, 3-C or 4-
C), 116.3 (CH, 6-C), 122.5 (CH, 3-C), 123.6 (CH, 6-C), 129.4 (CH,
5-C), 130.6 (CH, 3-C), 140.7 (quat, 2-C), 144.5 (quat, 4-C), 151.2
(quat, 4-C), 151.8 (quat, 1-C), 155.3 (quat, 1-C), 180.3 (quat, 2-C),
186.6 (quat, 5-C).
4.1.5.2. 2,5-Dinitrophenoxy-4-pentyl-2,5-benzoquinone 15b.
Prepared from 2,5-dinitro-2,5-dimethoxy-4-pentyldiphenylether
14b (1.41 g, 3.62 mmol). The crude product was puriﬁed by column
chromatography eluting with petroleum ether (60−80 °C):EtOAc
(75:25). 2,5-Dinitrophenoxy-4-pentyl-2,5-benzoquinone 15b was
isolated as a yellow solid (1.19 g, 3.31 mmol, 91.4%). Recrystallization
from EtOH produced golden prisms; mp 91−94 °C (Found: C, 56.4;
H, 4.5; N, 7.8%. C17H16N2O7 requires C, 56.7; H, 4.5; N, 7.8%.); m/z
383.2 (MNa)+; νmax/cm
−1 1676 and 1651 (CO, quinone), 1603
(CC), 1544 and 1343 (NO2), 1230 (C−O); δH (300 MHz, DMSO-
d6) 0.79 (3H, t, J = 6.9 Hz, 5-H), 1.24−1.19 (4H, m, 3-H and 4-H),
1.42−1.35 (2H, m, 2-H), 2.29 (2H, t, J = 6.9 Hz, 1-H), 6.18 (1H, s,
6-H), 6.675 (1H, s, 3-H), 8.23 (1H, dd, J = 9.0, 2.4 Hz, 4-H), 8.32
(1H, d, J = 9.0 Hz, 3-H), 8.41 (1H, d, J = 2.4 Hz, 6-H); δC (75 MHz,
DMSO-d6) 14.3 (CH3, 5-H), 22.3 (CH2, 3-C or 4-C), 27.75 (CH2,
2-C), 28.6 (CH2, 1-C), 31.4 (CH2, 3-C or 4-C), 115.1 (CH, 6-
C), 119.8 (CH, 6-C), 122.2 (CH, 4-C), 127.9 (CH, 3-C), 131.2 (CH,
3-C), 145.25 (quat, 2-C), 146.7 (quat, 5-C), 150.2 (quat, 4-C), 151.1
(quat, 1-C), 156.6 (quat, 1-C), 181.0 (quat, 2-C), 187.65 (quat, 5-
C).
4.1.6. 2,4-Diacetamido-4-pentyl-2,5-benzoquinone 12c. To a
solution of 2,4-dinitrophenoxy-4-pentyl-2,5-benzoquinone 8d (0.46
g, 1.26 mmol) in an EtOAc:MeOH (1:1, 20 mL) was added Pd/C 5%
(10% w/w of starting material). The resulting suspension was
hydrogenated in a Berghof apparatus for 3 h at a H2 pressure of 2.4
bar. Acetic anhydride (1.20 mL, 12.6 mmol) was added as soon as the
hydrogenation was stopped, and the resulting mixture was stirred at rt
overnight. The catalyst was removed by ﬁltration through a pad of
Celite, which was washed several times with MeOH. The ﬁltrate was
evaporated in vacuo, NaHCO3 (5%) added to the residue, and the
resulting mixture extracted with EtOAc (2 × 60 mL). The combined
organic layers were washed with NaHCO3 (5%, 70 mL) and brine
(100 mL) and dried (MgSO4). The solvent was removed in vacuo and
the crude product puriﬁed by column chromatography on silica eluting
with petroleum ether (60−80 °C):EtOAc (90:10). 2,4-Diacetamido-
4-pentyl-2,5-benzoquinone 12c was isolated as a dark-orange
crystalline solid (0.48 g, 1.24 mmol, 98.3%). Recrystallization from
hexane:EtOAc produced red prisms, mp 90−93 °C (Found: C, 65.6;
H, 6.4; N, 7.2%. C21H24N2O5 requires C, 65.6; H, 6.3; N, 7.3%.); m/z
341.0 (M − CH3CO)
−, 383.0 (M − H)−; νmax/cm
−1 3357 (N−H),
3269 (N−H), 2955 (C−H), 2929 (C−H), 1726 (CO), 1663 and
1647 (CO, quinone), 1599 (CC), 1206 (C−O); δH (300 MHz,
THF-d8) 0.93 (3H, t, J = 6.9 Hz, 5-H), 1.34−1.39 (4H, m, 3-H and
4-H), 1.48−1.55 (2H, m, 2-H), 2.04 (3H, s, 2-Ac or 4-Ac), 2.07
(3H, s, 2-Ac or 4-Ac), 2.40 (2H, dt, J = 7.5, 1.2 Hz, 1-H), 5.67 (1H, s,
6-H), 6.59 (1H, br s, 3-H), 6.98 (1H, d, J = 8.7 Hz, 6-H), 7.91 (1H,
dd, J = 9.0, 2.1 Hz, 5-H), 8.28 (1H, d, J = 2.1 Hz, 3-H), 8.63 (1H, s, 2-
NH), 9.31 (1H, s, 4-NH); δC (75 MHz, THF-d8) 13.3 (CH3, 5-C),
22.3 (CH2, 3-C or 4-C), 23.0 (CH3, 2-Ac or 4-Ac), 23.1 (CH3, 2-Ac
or 4-Ac), 27.85 (CH2, 2-C), 28.6 (CH2, 1-C), 31.5 (CH2, 3-C or
4-C), 110.8 (CH, 6-C), 112.5 (CH, 3-C), 114.9 (CH, 5-C), 120.7
(CH, 6-C), 130.45 (CH, 3-C), 131.3 (quat, 2-C), 137.15 (quat, 1-C),
138.2 (quat, 4-C), 149.8 (quat, 4-C), 158.2 (quat, 1-C), 167.7 (quat,
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2-Ac or 4-Ac, CO), 168.1 (quat, 2-Ac or 4-Ac, CO), 181.0 (quat,
2-C), 186.6 (quat, 5-C).
4.1.7. General Procedure for the Preparation of 8-Amino-
phenoxazin-3-one 2e and 7-Aminophenoxazin-3-one 17b. A
solution of 2,4-dinitrophenoxy-4-pentyl-2,5-benzoquinone 8d or
2,5-dinitrophenoxy-4-pentyl-2,5-benzoquinone 15b in EtOAc:-
MeOH (1:1) was hydrogenated in a Berghof apparatus in the
presence of Pd/C 5% (10% w/w of the starting material). The H2
pressure was set to 2.4 bar and reset to this pressure when necessary.
When the H2 pressure was steady, the reaction mixture was ﬁltered
through Celite, which was washed several times with MeOH. Either
AgO or Ag2O (3 mol equiv) was then added quickly to the ﬁltrate,
which rapidly produced a dark-purple−violet solution for 8-amino-
phenoxazinone derivatives and a dark-red−purple ﬂuorescent solution
for 7-aminophenoxazinone derivatives. Once the oxidative cyclization
was complete (TLC monitoring), the inorganic materials were
removed by ﬁltration through Celite, which was washed successively
with THF and MeOH. The combined ﬁltrates were evaporated in
vacuo and the residue subjected to column chromatography.
4.1.7.1. 8-Amino-2-pentyl-3H-phenoxazin-3-one 2e. Prepared
from 2,4-dinitrophenoxy-4-pentyl-2,5-benzoquinone 8d (0.38 g,
1.07 mmol); elution used a gradient mixture of petroleum ether
(60−80 °C):EtOAc (50:50 to 35:65), yielding 8-amino-2-pentyl-3H-
phenoxazin-3-one 2e as a dark-violet solid (0.29 g, 1.01 mmol, 94.7%),
mp 141−144 °C (Found: C, 71.9; H, 6.6; N, 9.65%. C17H18N2O2
requires C, 72.2; H, 6.4; N, 9.9%.); m/z 283.1 (MH)+; νmax/cm
−1
3400, 3337, and 3222 (N−H), 2853 and 2928 (C−H), 1639 (CO),
1585, 1566, and 1508 (CC); δH (300 MHz, DMSO-d6) 0.87 (3H, t,
J = 6.9 Hz, 5-H), 1.28−1.32 (4H, m, 3-H and 4-H), 1.46−1.56 (2H,
m, 2-H), 2.45 (2H, t, J = 6.9 Hz, 1-H), 5.41 (2H, br s, NH2), 6.17
(1H, s, 4-H), 6.90−6.93 (2H, m, 7-H and 9-H), 7.21 (1H, d, J = 9.3
Hz, 6-H), 7.25 (1H, s, 1-H); δC (75 MHz, DMSO-d6) 14.3 (CH3, 5-
C), 22.4 (CH2, 3-C or 4-C), 28.1 (CH2, 2-C), 29.5 (CH2, 1-C),
31.5 (CH2, 3-C or 4-C), 105.0 (CH, 4-C), 111.55 (CH, 9-C), 116.55
(CH, 6-C), 120.3 (CH, 7-C), 130.6 (CH, 1-C), 134.3 (quat, 8-C),
135.3 (quat, 9a-C), 147.25 (quat, 2-C or 5a-C), 147.3 (quat, 2-C or 5a-
C), 148.4 (quat, 4a-C), 149.7 (quat, 10a-C), 184.8 (quat, 3-C).
4.1.7.2. 7-Amino-2-pentyl-3H-phenoxazin-3-one 17b. Prepared
from 2,5-dinitrophenoxy-4-pentyl-2,5-benzoquinone 15b (0.80 g,
2.23 mmol); elution used a gradient mixture of petroleum ether (60−
80 °C):EtOAc (40:60 to 0:100), yielding 7-amino-2-pentyl-3H-
phenoxazin-3-one 17b as a dark-violet solid (0.62 g, 2.18 mmol,
97.6%); mp 250−254 °C (Found: C, 72.0; H, 6.6; N, 9.6%.
C17H18N2O2 requires C, 72.2; H, 6.4; N, 9.9%.); m/z 283.2 (MH)
+;
νmax/cm
−1 3420, 3329, and 3226 (N−H), 2923 (C−H), 1654 (C
O), 1599 and 1565 (CC); δH (300 MHz, DMSO-d6) 0.88 (3H, t, J
= 6.9 Hz, 5-H), 1.29−1.33 (4H, m, 3-H and 4-H), 1.47−1.54 (2-
H), 2.45 (2H, t, J = 7.5 Hz, 1-H), 6.17 (1H, s, 4-H), 6.51 (1H, d, J =
2.4 Hz, 6-H), 6.71 (1H, dd, J = 8.7, 2.4 Hz, 8-H), 6.83 (2H, br s,
NH2), 7.24 (1H, s, 1-H), 7.48 (1H, d, J = 8.7 Hz, 9-H); δC (75 MHz,
DMSO-d6) 14.4 (CH3, 5-C), 22.4 (CH2, 3-C or 4-C), 28.3 (CH2, 2-
C), 29.5 (CH2, 1-C), 31.55 (CH2, 3-C or 4-C), 97.8 (CH, 6-C),
105.1 (CH, 4-C), 113.8 (CH, 8-C), 126.4 (quat, 7-C), 130.8 (CH, 1-
C), 132.1 (CH, 9-C), 140.6 (quat, 9a-C), 144.0 (quat, 4a-C), 146.7
(quat, 10a-C), 149.8 (quat, 2-C), 155.1 (quat, 5a-C), 184.3 (quat, 3-
C).
4.1.8. 7-N-(N-tButoxycarbonyl-β-alanyl)amino-2-pentyl-3H-phe-
noxazin-3-one 20b. To N-tBoc-β-alanine (0.96 g, 5.07 mmol) in dry
THF (10 mL) at 2−3 °C (Tint) was added dropwise N-
methylpiperidine (0.72 mL, 5.92 mmol), followed after 5 min by iso-
butylchloroformate (0.66 mL, 5.07 mmol) and stirred at 3 °C for 1h.
Separately, Pd/C 5% (0.05g) was added to 7-amino-2-pentyl-3H-
phenoxazin-3-one 17b (0.48 g, 1.69 mmol) in dry DMF (5 mL) and
the mixture hydrogenated in a Berghof apparatus for 1 h at a hydrogen
pressure of 2 bar. After hydrogenation, the ﬂask was ﬂushed with N2
and sealed, then the suspension added via cannula to the anhydride
mixture and reacted for 72 h. The reaction mixture was quenched with
NaHCO3 (5%) and extracted with EtOAc (3 × 70 mL). The
combined organic extracts were washed successively with NaHCO3
(5%, 100 mL), water (100 mL), and brine (100 mL) and dried
(MgSO4). The solvent was evaporated in vacuo, and the residue was
subjected to column chromatography on silica, eluting with petroleum
ether (60−80 °C):EtOAc (40:60), yielding 7-N-(N-tbutoxycarbonyl-
β-alanyl)amino-2-pentyl-3H-phenoxazin-3-one 20b as an orange solid
(0.36 g, 0.78 mmol, 46.0%). Recrystallization from EtOAc produced
microcrystalline orange solid with a green metallic shine; mp 205−209
°C (Found: C, 66.35; H, 6.9; N, 9.25%. C25H21N3O5 requires C, 66.2;
H, 6.9; N, 9.3%.); m/z 454.3 (MH)+; νmax/cm
−1 3263 and 3190 (N−
H), 2951 and 2922 (C−H), 1710 (CO), 1651 (CO); δH (300
MHz, DMSO-d6) 0.79 (3H, t, J = 6.9 Hz, 5-H), 1.20−1.245 (4H, m,
3-H and 4-H), 1.30 (9H, s, C(CH3)3), 1.39−1.46 (2H, m, 2-H),
2.39 (2H, t, J = 7.5 Hz, 1-H), 2.47 (2H, t, J = 7.2 Hz, 2-H), 3.17 (2H,
q, J = 7.2 Hz, 3-H), 6.20 (1H, s, 4-H), 6.80 (1H, br s, NHtBoc), 7.22
(1H, s, 1-H), 7.40 (1H, dd, J = 8.7, 2.1 Hz, 8-H), 7.66 (1H, d, J = 8.7
Hz, 9-H), 7.82 (1H, d, J = 2.1 Hz, 6-H), 10.41 (1H, s, NH-Ar); δC (75
MHz, DMSO-d6) 14.3 (CH3, 5-C), 22.4 (CH2, 3-C or 4-C), 28.1
(CH2, 2-C), 28.7 (CH2, 1-C), 29.4 (CH3, C(CH3)3), 31.5 (CH2, 3-
C or 4-C), 36.8 (CH2, 3-C), 37.5 (CH2, 2-C), 78.2 (quat,
C(CH3)3), 105.3 (CH, 6-C), 106.05 (CH, 4-C), 116.8 (CH, 8-C),
129.6 (quat,7-C), 130.7 (CH, 9-C), 130.9 (CH, 1-C), 143.4 (quat, 9a-
C), 144.5 (quat, 5a-C), 146.7 (quat, 10a-C and 2-C), 149.5 (quat, 4a-
C), 156.0 (quat, tBoc CO), 170.8 (quat, 1-C), 185.1 (quat, 3-C).
4.1.9. 8-N-(N-tButoxycarbonyl-β-alanyl)amino-2-pentyl-3H-phe-
noxazin-3-one 21e. To N-tBoc-β-alanine (1.01 g, 5.34 mmol) in dry
THF (10 mL) at 2−3 °C (Tint) was added dropwise N-
methylpiperidine (0.76 mL, 6.23 mmol). After 5 min, iso-
butylchloroformate (0.69 mL, 5.34 mmol) was added dropwise, and
the solution stirred at 3 °C for 1 h before 8-amino-2-pentyl-3H-
phenoxazin-3-one 2e (0.50 g, 1.78 mmol) was added. The resulting
mixture was stirred under nitrogen for 48 h. The reaction mixture was
quenched with NaHCO3 (5%) and extracted with EtOAc (3 × 70
mL). The combined organic extracts were washed successively with
NaHCO3 (5%, 100 mL), water (100 mL), and brine (100 mL) and
dried (MgSO4). The solvent was evaporated in vacuo, and the residue
was subjected to column chromatography on silica gel, eluting with a
gradient mixture of petroleum ether (60−80 °C):EtOAc (35:65 to
20:80), yielding 8-N-(N-tbutoxycarbonyl-β-alanyl)amino-2-pentyl-3H-
phenoxazin-3-one 21e as an orange solid (0.73 g, 1.60 mmol, 90.1%);
mp 176−179 °C (Found: C, 66.2; H, 6.8; N, 9.1%. C25H31N3O5
requires C, 66.2; H, 6.9; N, 9.3%.); m/z 454.3 (MH)+, 476.3 (MNa)+;
νmax/cm
−1 3322 (N−H), 2954 and 2930 (C−H), 1684 (CO), 1658
(CO), 1648 (CO), 1171 (C−O); δH (300 MHz, DMSO-d6) 0.78
(3H, t, J = 6.6 Hz, 5-H), 1.21−1.23 (4H, m, 3-H and 4-H), 1.30
(9H, s, C(CH3)3), 1.38−1.40 (2H, m, 2-H), 2.34 (2H, t, J = 7.2 Hz,
1-H), 2.42 (2H, t, J = 6.6 Hz, 2-H), 3.19 (2H, q, J = 6.6 Hz, 3-H),
6.095 (1H, s, 4-H), 6.77 (1H, br s, NHtBoc), 7.15 (1H, s, 1-H), 7.28
(1H, d, J = 8.7 Hz, 6-H), 7.60 (1H, dd, J = 8.7, 2.4 Hz, 7-H), 8.00 (1H,
d, J = 2.1 Hz, 9-H), 10.08 (1H, s, NH-Ar); δC (75 MHz, DMSO-d6)
14.3 (CH3, 5-C), 22.4 (CH2, 3-C or 4-C), 28.0 (CH2, 2-C), 28.7
(CH3, C(CH3)3), 29.4 (CH2, 1-C), 31.5 (CH2, 3-C or 4-C), 36.95
(CH2, 3-C), 37.3 (CH2, 2-C), 78.1 (quat, C(CH3)3), 105.8 (CH, 4-
C), 116.5 (CH, 6-C), 119.0 (CH, 9-C), 124.0 (CH, 7-C), 130.7 (CH,
1-C), 133.3 (quat, 9a-C), 137.0 (quat, 8-C), 139.3 (quat, 5a-C), 147.6
(quat, 2-C), 149.2 (quat, 4a-C or 10a-C), 149.3 (quat, 4a-C or 10a-C),
156.0 (quat, tBoc CO), 170.05 (quat, 1-C), 185.1 (quat, 3-C).
4.1.10. General Procedure for the Removal of N-tButoxycarbonyl
Group. The corresponding N-tbutoxycarbonyl protected compound
was dissolved in an excess of neat TFA, and the resulting solution was
swirled for 1 min. The TFA was evaporated in vacuo, then sequential
portions of MeOH were added to the residue and evaporated. The
residue was redissolved in minimal MeOH and diluted with Et2O.
After overnight standing, the microcrystalline solid that formed was
collected and washed with Et2O. The ﬁltrate was evaporated under
reduced pressure for further recovery of the product.
4.1.10.1. 7-N-(β-Alanyl)amino-2-pentyl-3H-phenoxazin-3-one
TFA Salt 22b. Prepared from 7-N-(N-tbutoxycarbonyl-β-alanyl)-
amino-2-pentyl-3H-phenoxazin-3-one 20b (0.14 g, 0.30 mmol). 7-N-
(β-Alanyl)amino-2-pentyl-3H-phenoxazin-3-one TFA salt 22b was
isolated as a brown−red solid with a green metallic shine (0.12 g, 0.27
mmol, 88.5%); mp 213−223 °C; HRMS (Found (M)+, 354.1815.
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Calcd for C20H24N3O3: (M)
+, 354.1812.); m/z 354.2 (M+) νmax/cm
−1
3263 (N−H), 3188−3060 (N+-H), 2928 (C−H), 1674 (CO), 1651
(CO); δH (300 MHz, DMSO-d6) 0.88 (3H, t, J = 6.9 Hz, 5-H),
1.30−1.33 (4H, m, 3-H and 4-H), 1.485−1.53 (2H, m, 2-H), 2.45
(2H, t, J = 7.5 Hz, 1-H), 2.82 (2H, t, J = 6.3 Hz, 2-H), 3.15 (2H, t, J
= 6.3 Hz, 3-H), 6.25 (1H, s, 4-H), 7.26 (1H, s, 1-H), 7.50 (1H, dd, J
= 8.7, 1.8 Hz, 8-H), 7.73 (1H, d, J = 8.7 Hz, 9-H), 7.89 (1H, d, J = 1.8
Hz, 6-H), 7.97 (3H, br s, NH3
+), 10.83 (1H, s, NH-Ar) (Figure S10 in
the Supporting Information); δC (75 MHz, DMSO-d6) 14.4 (CH3, 5-
C), 22.4 (CH2, 3-C or 4-C), 28.1 (CH2, 2-C), 29.4 (CH2, 1-C),
31.5 (CH2, 3-H or 4-H), 34.1 (CH2, 2-C), 35.2 (CH2, 3-C), 105.5
(CH, 6-C), 106.1 (CH, 4-C), 116.8 (CH, 8-C), 129.8 (quat, 7-C),
130.8 (CH, 9-C or 1-C), 130.9 (CH, 9-C or 1-C), 143.1 (quat, 9a-C),
144.4 (quat 5a-C), 146.7 (quat, 2-C or 10a-C), 146.8 (quat, 2-C or
10a-C), 149.4 (quat, 4a-C), 169.7 (quat, 1-C), 185.1 (quat, 3-C).
4.1.10.2. 8-N-(β-Alanyl)amino-2-pentyl-3H-phenoxazin-3-one
TFA Salt 23e. Prepared from 8-N-(N-tbutoxycarbonyl-β-alanyl)-
amino-2-pentyl-3H-phenoxazin-3-one 21e (0.08 g, 0.18 mmol). 8-N-
(β-Alanyl)amino-2-pentyl-3H-phenoxazin-3-one TFA salt 23e was
isolated as a dark-red solid (0.07 g, 0.15 mmol, 87.0%); mp 132−139
°C; HRMS (Found (M)+, 354.1813. Calcd for C20H24N3O3: (M)
+,
354.1812.); m/z 354.2 (M+); νmax/cm
−1 3312 (N−H), 3077 (N+−H),
2932−2861 (C−H), 1672 (CO), 1649 (CO); δH (300 MHz,
DMSO-d6) (Figure S15 in the Supporting Information) 0.80 (3H, t, J
= 6.6 Hz, 5-H), 1.22−1.25 (4H, m, 3-H and 4-H), 1.425−1.47 (2H,
m, 2-H), 2.41 (2H, t, J = 8.1 Hz, 1-H), 2.67 (2H, t, J = 6.6 Hz, 2-H),
3.05 (2H, br s, 3-H), 6.21 (1H, s, 4-H), 7.27 (1H, s, 1-H), 7.40 (1H,
d, J = 9.0 Hz, 6-H), 7.65 (1H, dd, J = 9.0, 2.4 Hz, 7-H), 7.75 (3H, br s,
NH3
+), 8.08 (1H, d, J = 2.4 Hz, 9-H), 10.39 (1H, s, NH-Ar); δC (75
MHz, DMSO-d6) 14.3 (CH3, 5-C), 22.4 (CH2, 3-C or 4-C), 28.1
(CH2, 2-C), 29.4 (CH2, 1-C), 31.5 (CH2, 3-C or 4-C), 33.9 (CH2,
2-C), 35.4 (CH2, 3-C), 105.9 (CH, 4-C), 116.7 (CH, 6-C), 119.2
(CH, 9-C), 124.1 (CH, 7-C), 130.9 (CH, 1-C), 133.4 (quat, 9a-C),
136.7 (quat, 8-C), 139.6 (quat, 5a-C), 147.75 (quat, 2-C), 149.4 (quat,
4a-C or 10a-C), 149.5 (quat, 4a-C or 10a-C), 169.0 (quat, 1-C),
185.2 (quat, 3-C). LC-MS spectra are provided as Figure S7 in the
Supporting Information.
4.2. Microbiology. 4.2.1. Preparation of Columbia Agar
Solution. Standard Columbia agar was prepared according to the
manufacturer’s recommendations: Columbia agar (41g) was dissolved
by boiling in sterile deionized water (1 L). The resulting medium was
sterilized by autoclaving at 121 °C for 15 min and then cooled and
maintained at 50 °C in a water bath before incorporation of the
substrates.
4.2.2. Preparation of Substrate-Containing Plates. A 10g/L stock
solution of each substrate to be tested was prepared in DMSO or N-
methylpyrrolidone (100 μL). The stock solutions were incorporated
into Columbia agar (Oxoid, Basingstoke) to give a ﬁnal substrate
concentration of 50 mg/L for the spot test plates and 40 mg/L for the
single bacterial species streaked plates. The ﬁnal media were poured
into separate sterile Petri dishes and left to set into a gel.
4.2.3. Bacterial Suspension Preparation. The bacterial strains were
obtained from the American Type Culture Collection (ATCC,
Cockeysville, USA), the National Collection of Type Cultures
(NCTC, Colindale, UK), or isolated from clinical material obtained
from patients in the Freeman Hospital (Newcastle-upon-Tyne). In this
case, the microorganisms were identiﬁed according to standard
procedures. Colonies of each strain were suspended in sterile
deionized water to generate a suspension with a turbidity equivalent
to 0.5 McFarland units (approximately 1.5 × 108 colony forming units
per mL), as conﬁrmed with a densitometer. One microliter of this
suspension was inoculated onto the agar plates containing the various
substrates using an automated multipoint inoculator.
4.2.4. Spot Test Plates. The agar plates (4.2.2) were each
inoculated with 10 Gram negative bacteria, eight Gram positive
bacteria, and two yeasts (from the National Collection of Type
Cultures, London, UK). All inoculated plates were incubated at 37 °C
for 24 h and then examined visually for the presence of growth and
coloration of bacterial colonies.
4.2.5. Individual Bacterial Species Streaked Plates. For each strain
tested, a bacterial suspension was prepared in saline 0.85% at a
standard inoculum of 0.5 McFarland (1.5 × 108 colony forming units
per mL), using a densitometer. Using a sterile loop, 10 μL of the
bacterial suspension was inoculated onto a test plate containing a
particular substrate. The plates were then incubated aerobically at 37
°C and visual inspections made at 24 h and 48 h of incubation.
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acs.jmed-
chem.5b01591.
Synthetic methods and spectral characterization of
synthetic intermediates and products; selected LC-MS
and NMR spectra of key intermediates and products
(PDF)
Molecular formula strings (CSV)
■ AUTHOR INFORMATION
Corresponding Author
*Phone: +44 191 5152591. E-mail: roz.anderson@sunderland.
ac.uk.
Present Address
⊥P.W.G. now at Faculty of Pharmacy, The University of
Sydney, Sydney New South Wales 2006, Australia.
Notes
The authors declare no competing ﬁnancial interest.
#Deceased.
■ ACKNOWLEDGMENTS
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